InsiderGauge
Checking updates…
Dashboard

PMVPPMV Pharmaceuticals, Inc.

Market cap
$95.90M
as of 2026-10-23
Latest close
$1.27
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2023-11-13

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Eckler Matthew JosephOct 1Oct 5A · derivative84,000$1.75$147,00084,000NoForm 4
Levine Arnold JJun 4Jun 5A · derivative42,000$1.19$49,98042,000NoForm 4
Gallagher Carol GiltnerJun 4Jun 5A · derivative42,000$1.19$49,98042,000NoForm 4
Gallagher Carol GiltnerJun 4Jun 5G · derivative42,000$1.19$49,980not reportedNoForm 4
Gallagher Carol GiltnerJun 4Jun 5G · derivative42,000$1.19$49,98042,000NoForm 4
Baum Charles MJun 4Jun 5A · derivative42,000$1.19$49,98042,000NoForm 4
Stelzer LaurieJun 4Jun 5A · derivative42,000$1.19$49,98042,000NoForm 4
Flowers KirstenJun 4Jun 5A · derivative42,000$1.19$49,98042,000NoForm 4
Mack David HenryPresident and CEOMar 5Mar 9A · derivative744,960$1.53$1,139,789744,960NoForm 4
Ticktin RobertGeneral Counsel & COOMar 5Mar 9A · derivative319,270$1.53$488,483319,270NoForm 4
Jalota DeepikaChief Development OfficerMar 5Mar 9A · derivative303,310$1.53$464,064303,310NoForm 4
Carulli MichaelChief Financial OfficerMar 5Mar 9A · derivative240,000$1.53$367,200240,000NoForm 4
Mack David HenryPresident and CEOOct 27, 2025Oct 29, 2025M220,643$1.37$302,281451,109NoForm 4
Mack David HenryPresident and CEOOct 27, 2025Oct 29, 2025M · derivative220,643$1.37$302,281not reportedNoForm 4
OrbiMed Capital GP V LLCOct 23, 2025Oct 27, 2025S1,000,000$1.52Sale −$1,520,0004,975,291NoForm 4
Orbimed Advisors LLCSep 10, 2025Sep 12, 2025S500,000$1.80Sale −$900,0005,975,291NoForm 4
Mack David HenryPresident and CEOJul 1, 2025Jul 3, 2025S58,411$1.06Sale −$61,916536,133NoForm 4
Carulli MichaelChief Financial OfficerJul 1, 2025Jul 3, 2025S28,249$1.06Sale −$29,94460,146NoForm 4
Jalota DeepikaChief Development OfficerJul 1, 2025Jul 3, 2025S33,065$1.06Sale −$35,04989,959NoForm 4
Ticktin RobertGeneral Counsel & COOJul 1, 2025Jul 3, 2025S23,151$1.06Sale −$24,54098,695NoForm 4
Baum Charles MJun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Flowers KirstenJun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Gallagher Carol GiltnerJun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Gallagher Carol GiltnerJun 5, 2025Jun 9, 2025G · derivative33,500$0.95$31,825not reportedNoForm 4
Gallagher Carol GiltnerJun 5, 2025Jun 9, 2025G · derivative33,500$0.95$31,82533,500NoForm 4
Heyman Richard A.Jun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Levine Arnold JJun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Stelzer LaurieJun 5, 2025Jun 9, 2025A · derivative33,500$0.95$31,82533,500NoForm 4
Mack David HenryPresident and CEOMar 3, 2025Mar 5, 2025A · derivative800,000$1.32$1,056,000800,000NoForm 4
Jalota DeepikaChief Development OfficerMar 3, 2025Mar 5, 2025A · derivative300,000$1.32$396,000300,000NoForm 4
Carulli MichaelChief Financial OfficerMar 3, 2025Mar 5, 2025A · derivative265,000$1.32$349,800265,000NoForm 4
Mack David HenryPresident and CEOJan 3, 2025Jan 22, 2025M17,709$0.53$9,386551,919NoForm 4
Mack David HenryPresident and CEOJan 3, 2025Jan 22, 2025M · derivative17,709$0.53$9,386not reportedNoForm 4
Mack David HenryPresident and CEODec 3, 2024Jan 22, 2025M91,750$0.53$48,628534,210NoForm 4
Mack David HenryPresident and CEODec 3, 2024Jan 22, 2025M · derivative91,750$0.53$48,62817,709NoForm 4
Mack David HenryPresident and CEOAug 13, 2024Oct 3, 2024D · derivative134,584$28.33$3,812,765not reportedNoForm 4
Mack David HenryPresident and CEOAug 13, 2024Oct 3, 2024D · derivative249,600$16.29$4,065,984not reportedNoForm 4
Mack David HenryPresident and CEOAug 13, 2024Oct 3, 2024A · derivative384,184$1.48$568,592384,184NoForm 4
Mack David HenryPresident and CEOAug 13, 2024Oct 3, 2024D · derivative330,000$5.70$1,881,000not reportedNoForm 4
Mack David HenryPresident and CEOAug 13, 2024Oct 3, 2024A · derivative330,000$1.48$488,400330,000NoForm 4
Carulli MichaelChief Financial OfficerAug 13, 2024Oct 3, 2024D · derivative13,605$28.33$385,430not reportedNoForm 4
Carulli MichaelChief Financial OfficerAug 13, 2024Oct 3, 2024D · derivative27,200$16.29$443,088not reportedNoForm 4
Carulli MichaelChief Financial OfficerAug 13, 2024Oct 3, 2024A · derivative40,805$1.48$60,39140,805NoForm 4
Carulli MichaelChief Financial OfficerAug 13, 2024Oct 3, 2024D · derivative75,000$5.70$427,50075,000NoForm 4
Carulli MichaelChief Financial OfficerAug 13, 2024Oct 3, 2024A · derivative75,000$1.48$111,00075,000NoForm 4
Jalota DeepikaChief Development OfficerAug 13, 2024Oct 3, 2024D · derivative22,674$28.33$642,354not reportedNoForm 4
Jalota DeepikaChief Development OfficerAug 13, 2024Oct 3, 2024D · derivative68,100$16.29$1,109,349not reportedNoForm 4
Jalota DeepikaChief Development OfficerAug 13, 2024Oct 3, 2024A · derivative90,774$1.48$134,34690,774NoForm 4
Jalota DeepikaChief Development OfficerAug 13, 2024Oct 3, 2024D · derivative125,000$5.70$712,500not reportedNoForm 4
Jalota DeepikaChief Development OfficerAug 13, 2024Oct 3, 2024A · derivative125,000$1.49$186,250125,000NoForm 4
Carulli MichaelChief Financial OfficerSep 11, 2024Sep 12, 2024S2,891$1.50Sale −$4,33788,395NoForm 4
Jalota DeepikaChief Development OfficerSep 11, 2024Sep 12, 2024S7,218$1.50Sale −$10,827118,283NoForm 4
Gallagher Carol GiltnerJun 7, 2024Jun 10, 2024G · derivative67,500$1.65$111,375not reportedNoForm 4
Gallagher Carol GiltnerJun 7, 2024Jun 10, 2024G · derivative67,500$1.65$111,37567,500NoForm 4
Baum Charles MJun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Flowers KirstenJun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Gallagher Carol GiltnerJun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Heyman Richard A.Jun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Levine Arnold JJun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Stelzer LaurieJun 6, 2024Jun 10, 2024A · derivative67,500$1.65$111,37567,500NoForm 4
Mack David HenryPresident and CEOJan 18, 2024Jan 22, 2024A163,890$0.00$0442,460NoForm 4
Mack David HenryPresident and CEOJan 18, 2024Jan 22, 2024A · derivative519,915$1.80$935,847519,915NoForm 4
Carulli MichaelChief Financial OfficerJan 18, 2024Jan 22, 2024A82,220$0.00$091,286NoForm 4
Carulli MichaelChief Financial OfficerJan 18, 2024Jan 22, 2024A · derivative204,630$1.80$368,334204,630NoForm 4
Jalota DeepikaChief Development OfficerJan 18, 2024Jan 22, 2024A95,555$0.00$0125,501NoForm 4
Jalota DeepikaChief Development OfficerJan 18, 2024Jan 22, 2024A · derivative225,095$1.80$405,171225,095NoForm 4
OrbiMed Genesis GP LLCNov 22, 2023Nov 24, 2023S87,786$2.23Sale −$195,763not reportedNoForm 4
Mack David HenryPresident and CEONov 10, 2023Nov 13, 2023G85,307$0.00$0278,570NoForm 4
Mack David HenryPresident and CEONov 10, 2023Nov 13, 2023G85,307$0.00$0165,307NoForm 4
Mack David HenryPresident and CEOOct 18, 2023Nov 13, 2023M198,407$0.53$105,156363,877NoForm 4
Mack David HenryPresident and CEOAug 7, 2023Nov 13, 2023M · derivative198,407$0.53$105,156109,459NoForm 4